Patent · US Active

Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use

US8012704B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2010
Grant dateSep 6, 2011
Priority date
Expiry dateJul 6, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/495
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the molecule referred to as ALK-1, and its role as a type I receptor for members of the TGF-β family. The molecule has a role in the phosphorylation of Smad-5 and Smad1, which also act as activators of certain genes. Aspects of the invention relate to this interaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.